Zuen Ren, Huizhi Liang, Phillip M. Galbo Jr, Malindrie Dharmaratne, Ameya S. Kulkarni, Atefeh Taherian Fard, Marie Louise Aoun, Nuria Martinez-Lopez, Kimita Suyama ...
A variety of strategies have been designed to modulate redox levels. Chemotherapy, radiotherapy, and nanoparticles that generate ROS result in oxidative damage and immunogenic cell death at tumor ...
Blocking a single protein revs up T cells, boosting their energy reserves and helping them fight tumors longer in new mouse ...
PSA is a validated FDA-recognized clinical endpoint in assessing prostate cancer treatment response; Telomir-1 lowered PSA levels in a dose-related manner. MIAMI, FLORIDA / ACCESS Newswire / November ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback